Cisplatin Injection

Fresenius Kabi USA, LLC

Revision date : 2024-02-16

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS05 GHS08 GHS07 GHS06
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

General Information

Version

02/16/2024

Revision date

2024-02-16

Product name

Cisplatin Injection

Product name

Cisplatin Injection

Identification on the label/Trade name

Cisplatin Injection | Manufacturer Fresenius Kabi USA LLC

Manufacturer Name

Fresenius Kabi USA, LLC

Icons in SDS

GHS05 GHS06 GHS07 GHS08 M004 M009 M010 M011 M013 M017 M026 M059

Company Information

company name

Fresenius Kabi USA, LLC

GHS Information

Signal word

DANGER

Hazard Codes

Hazard statements (CLP)

H300, H314, H317, H318, H334, H350, H361, H362

Hazard statements

Code

Statements

H300

Fatal if swallowed

Section 2

Signal word

DANGER. GHS Class Acute Oral Toxicity. Category 2. Serious Eye Damage. category 1. Skin corrosion. category 1. Respiratory sensitisation. category 1. Carcinogenicity. Category 1B. Reproductive toxicity. Category 2. Skin Sensitization. category 1. Reproductive toxicity. Effects on or via lactation.

Hazard statements

Fatal if swallowed. Causes serious eye damage. Causes severe skin burns and eye damage. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause cancer. Suspected of damaging fertility or the unborn child. May cause an allergic skin reaction. May cause harm to breast-fed children.

Precautionary statements

Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Avoid breathing dust/fume/gas/mist/vapours/spray. Avoid contact during pregnancy and while nursing. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves/protective clothing/eye protection/face protection. In case of inadequate ventilation wear respiratory protection. IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician IF SWALLOWED: Rinse mouth. Do not induce vomiting. IF ON SKIN: Wash with plenty of water. IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF exposed or concerned: Get medical advice/attention. Immediately call a POISON CENTER or doctor/physician. Specific treatment (see ... on this label). Rinse mouth. If skin irritation or rash occurs: Get medical advice/attention. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Take off contaminated clothing and wash it before reuse. Wash contaminated clothing before reuse. Store locked up. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.

Principle Routes of Exposure

Inhalation Ingestion Eye contact Skin Absorption. Injection.

Potential health effects

Eye Contact with eyes may cause irritation. Signs/Symptoms Adverse events from therapeutic doses include: nephrotoxicity, neuropathies, myelosuppression (leukopenia, thrombocytopenia, and anemia), fever, infection, nausea, vomiting, ototoxicity, tinnitis, hearing loss, deafness, and vestibular toxicity. Anaphylactic-like reactions of facial edema, bronchoconstriction, tachycardia, and hypotension have also been reported. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing Individuals with pre-existing renal impairment, myelosuppression, hearing impairment, or previous Conditions history of allergic reaction to cisplatin or other platinumcontaining compounds.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.